Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens.
about
Assessment of treatment response in tuberculosisDecay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis casesHypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesThe spectrum of latent tuberculosis: rethinking the biology and intervention strategiesIsolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.Temporal dynamics of interferon gamma responses in children evaluated for tuberculosisHigh-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected childrenTuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling.Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapyKinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.CREB is a positive transcriptional regulator of gamma interferon in latent but not active tuberculosis infections.Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individualsEvaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populationsIsoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trialPersistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary reportEffect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis.T cell monitoring of chemotherapy in experimental rat tuberculosis.Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients.Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot studySerial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population.Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individualsCombinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk StratificationUnderstanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndromeLongitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development.Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay resultsRadiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy RegimensEffect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis.
P2860
Q28384421-B230323C-2730-4190-9FDF-47CA216EFC0FQ28475371-FCEBF3E3-F6FA-422B-8AF6-0ACC7233D81BQ28476626-017AB59A-F1B0-49D7-B5FB-80962B1B6857Q29619404-EE743878-CC46-45FB-931B-5D7335FAD558Q33293104-FC29D766-5318-4160-9716-2176BBE9EA1BQ33397721-89C2C7C9-8931-4E86-BC36-20D132209924Q33454961-60DB543E-E13E-4F6B-8D28-83C2B0B76C4DQ33567995-8F5D0D48-0A2C-492D-9D15-D434D8CD5517Q33589272-363DE6EA-8997-44FC-9FE0-525A0169D017Q33591688-33CD78AB-E31C-4157-8ECE-468599DAC882Q33747557-17EAC2AD-C105-4F1E-8C37-63B7EA5A61E8Q33807147-4C131F93-8283-4248-B021-4051A65BD7EBQ33905874-6828D204-765F-44EB-8B24-761193C80B30Q33909191-BB63A812-0C10-4084-9312-CB47FCD14239Q34055234-A3FACA84-5BEA-410B-AA4B-D0E0992BD3E9Q34150351-8F248EDB-0CA5-4013-B437-B7BD91CA861CQ34251506-B71B0F6C-FDF4-4935-BC36-05C04FD7C2DFQ34299551-5CDC3136-8C96-4FF1-B481-ED916C1BF3C2Q34432005-72B8BC1B-3DB5-4C82-9B72-DDE083E27C40Q34519039-1D998F95-9DAA-4F8A-9912-7F08A669238EQ34691255-EF3188A8-0707-4A17-96C1-CC77A7B74D7AQ35054208-1B436C5F-8741-48AA-9CF8-831BCF53A7AEQ35139430-9822581F-1CC0-4A17-B38B-79DF69FFD7F0Q35201537-3238272B-EAB1-4051-B19D-690E0B4F5BF2Q35606554-FBBCA83D-E494-4D74-BC55-91F9A3F0FEC6Q35629697-66D04F05-1887-411C-B3B9-9891E53334FCQ35782733-0055DAA6-147F-4DEF-A868-0C7674D29C76Q35818084-6A608A2D-1352-4C07-8123-347545433BB4Q35840672-128ABAC6-477F-4038-AAE4-31FBFA2831FBQ35855200-3C2F56BF-9EFA-4023-92EB-DADF19556945Q36128602-CE83162E-3814-4D9E-9DA5-94A103D826D6Q36238015-0B73E33E-1EFB-4A6E-916C-35554DD47407Q36238260-D448E2EF-5283-4B07-B81B-4A99B48B7A2EQ36314099-FA6374CF-834D-4AAF-9E64-66D75F892A21Q36516077-AB04FE2E-9756-474A-99FA-7708A678660AQ36606393-3EFADB4B-B808-4A98-99E3-E268A10DCFDBQ37124117-36FB9C4D-D506-42AF-8F7C-65A1C5B26B20Q37615219-DD8DE9E7-903D-4C2F-8027-97678A61F56AQ37649784-3B673BC5-DB90-48E1-BA0B-3B403F5E0167Q37724458-D0C35A71-E321-4107-BBED-F083B8FC825E
P2860
Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effect of treatment of latent ...... cterium tuberculosis antigens.
@en
Effect of treatment of latent ...... cterium tuberculosis antigens.
@nl
type
label
Effect of treatment of latent ...... cterium tuberculosis antigens.
@en
Effect of treatment of latent ...... cterium tuberculosis antigens.
@nl
prefLabel
Effect of treatment of latent ...... cterium tuberculosis antigens.
@en
Effect of treatment of latent ...... cterium tuberculosis antigens.
@nl
P2093
P50
P356
P1476
Effect of treatment of latent ...... cterium tuberculosis antigens.
@en
P2093
Geoffrey Pasvol
Robert N Davidson
Sandra M Newton
P304
P356
10.1086/499311
P407
P577
2005-12-29T00:00:00Z